Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Gufic BioSciences Ltd Financial Statements & Historical Data

Updated
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 2 October 2026, 8:37 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price418₹ per share
Reported P/E57.1Times
Book value per share66.2₹ per share
Reported ROCE12.2 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 2 October 2026, 8:37 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap4,196 Cr.
Current Price418
High / Low468/268
Stock P/E57.1
Book Value66.2
Dividend Yield0.02 %
ROCE12.2 %
ROE9.98 %
Face Value1.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Gufic BioSciences Ltd 4,196 Cr. 418 468/26857.1 66.20.02 %12.2 %9.98 % 1.00
Zota Health Care Ltd 4,391 Cr. 1,268 1,740/1,022 2000.08 %8.47 %15.0 % 10.0
SMS Pharmaceuticals Ltd 4,414 Cr. 471 494/26248.8 85.90.08 %12.9 %11.9 % 1.00
Aarti Drugs Limited 3,842 Cr. 421 534/31922.2 1540.48 %11.7 %12.7 % 10.0
Unichem Laboratories Ltd 3,767 Cr. 535 687/27830.8 3860.00 %4.13 %3.17 % 2.00
Industry Average17,573.63 Cr1,250.1655.08211.240.39%26.16%16.59%6.06

All Competitor Stocks of Gufic BioSciences Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 195215202195203204208205227230231252261
Expenses 160176165161167166174178195195195206214
Operating Profit 35393634363934273236364647
OPM % 18%18%18%18%18%19%16%13%14%16%16%18%18%
Other Income 10011020121-10
Interest 44345558910899
Depreciation 4444445888888
Profit before tax 28313027282926111621212830
Tax % 26%25%25%26%26%26%26%26%26%27%26%26%26%
Net Profit 2123222021221981215162122
EPS in Rs 2.132.392.222.002.082.171.930.791.201.491.552.052.24

Last Updated: September 29, 2026, 8:59 pm

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: August 25, 2026, 6:30 am

MetricMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 148201245306351379488779691807820940974
Expenses 134181222267305327404631556657683790810
Operating Profit 14202339465284148135150136150165
OPM % 10%10%9%13%13%14%17%19%20%19%17%16%17%
Other Income 111446433-0432
Interest 46691014145817253737
Depreciation 444451416192217213131
Profit before tax 7101430353058127107116948599
Tax % 36%29%37%45%38%25%23%24%25%26%26%26%
Net Profit 47916222344968086706374
EPS in Rs 0.540.951.172.132.822.925.689.898.228.596.976.307.33
Dividend Payout % 9%5%4%2%2%2%2%1%1%1%1%2%

YoY Net Profit Growth

Year2015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)75.00%28.57%77.78%37.50%4.55%91.30%118.18%-16.67%7.50%-18.60%-10.00%
Change in YoY Net Profit Growth (%)0.00%-46.43%49.21%-40.28%-32.95%86.76%26.88%-134.85%24.17%-26.10%8.60%

Gufic BioSciences Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2015-2016 to 2025-2026.

Growth

Compounded Sales Growth
10 Years:19%
5 Years:17%
3 Years:2%
TTM:4%
Compounded Profit Growth
10 Years:33%
5 Years:25%
3 Years:-10%
TTM:-29%
Stock Price CAGR
10 Years:30%
5 Years:35%
3 Years:16%
1 Year:-7%
Return on Equity
10 Years:23%
5 Years:22%
3 Years:18%
Last Year:12%

Last Updated: September 5, 2025, 5:30 am

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: September 30, 2026, 8:37 pm

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 8888810101010101010
Reserves 1926304668120164259338523591654
Borrowings 33435780981266264334333336405
Other Liabilities 677584104106152157188179227232273
Total Liabilities 1271521782382804083925218611,0931,1701,342
Fixed Assets 252222232483100115160159506491
CWIP 0002103113411703072222
Investments 000000001233
Other Assets 102130156213245294279365531625639826
Total Assets 1271521782382804083925218611,0931,1701,342
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 11-4-4-554787106-27-712344
Cash from Investing Activity + -2-1-5-9-13-43-7-95-191-102-72-31
Cash from Financing Activity + -557148-4-79-623482-3732
Net Cash Flow 4-0-11-002517-271445
Free Cash Flow 9-5-8-13-877519-214-1165213
CFO/OP 92%-8%2%30%33%110%115%94%1%13%107%37%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow9.00-5.00-8.00-13.00-8.007.0075.0019.00-214.00-116.0052.0013.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. Check the source for the accounting basis. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 858210278971071039371109149140
Inventory Days 144165180190238190249138102202188211
Days Payable 176223188132192157238162125143156155
Cash Conversion Cycle 5425941361431411146948167181197
Working Capital Days 20418142640176350689793
ROCE %17%18%24%24%33%30%21%29%46%23%17%13%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 75.00%72.51%72.51%72.51%72.51%72.51%72.51%72.51%72.50%72.50%72.50%72.50%
FIIs 0.72%0.47%0.12%0.23%0.23%0.30%0.31%0.32%0.33%0.44%0.42%0.47%
DIIs 1.63%1.72%2.20%2.38%2.51%2.99%3.39%3.38%3.66%3.74%3.83%3.67%
Public 22.64%25.29%25.17%24.89%24.75%24.20%23.79%23.81%23.51%23.30%23.23%23.36%
No. of Shareholders 36,55734,42434,69532,25032,82533,29931,84431,87631,42030,36229,22329,753
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
ICICI Prudential Multicap Fund 1,480,998 0.29 45.5N/AN/AN/A
SBI Healthcare Opportunities Fund 1,000,000 0.8 30.731,000,0002025-04-22 17:25:340%
ICICI Prudential Smallcap Fund 446,517 0.17 13.72441,2932025-12-15 09:10:001.18%
Bank of India Small Cap Fund 353,689 0.59 10.87348,4632026-01-25 06:13:371.5%
ICICI Prudential ELSS Tax Saver Fund 74,008 0.02 2.27N/AN/AN/A
ICICI Prudential Bharat Consumption Fund 58,263 0.06 1.7939,1972026-02-23 03:46:1748.64%

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Distributions & retention

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24
FaceValue 1.001.00
Basic EPS (Rs.) 6.958.74
Diluted EPS (Rs.) 6.958.74
Cash EPS (Rs.) 9.0510.29
Book Value[Excl.RevalReserv]/Share (Rs.) 59.9453.11
Book Value[Incl.RevalReserv]/Share (Rs.) 59.9453.11
Revenue From Operations / Share (Rs.) 81.7580.44
PBDIT / Share (Rs.) 13.9314.76
PBIT / Share (Rs.) 11.8313.07
PBT / Share (Rs.) 9.3911.54
Net Profit / Share (Rs.) 6.958.59
NP After MI And SOA / Share (Rs.) 6.958.59
PBDIT Margin (%) 17.0418.35
PBIT Margin (%) 14.4716.24
PBT Margin (%) 11.4814.33
Net Profit Margin (%) 8.4910.67
NP After MI And SOA Margin (%) 8.4910.67
Return on Networth / Equity (%) 11.5816.17
Return on Capital Employeed (%) 15.1718.18
Return On Assets (%) 5.957.88
Long Term Debt / Equity (X) 0.210.28
Total Debt / Equity (X) 0.510.59
Asset Turnover Ratio (%) 0.720.00
Current Ratio (X) 1.611.61
Quick Ratio (X) 1.051.08
Inventory Turnover Ratio (X) 3.930.00
Dividend Payout Ratio (NP) (%) 1.431.12
Dividend Payout Ratio (CP) (%) 1.100.93
Earning Retention Ratio (%) 98.5798.88
Cash Earning Retention Ratio (%) 98.9099.07
Interest Coverage Ratio (X) 5.709.64
Interest Coverage Ratio (Post Tax) (X) 3.846.61
Enterprise Value (Cr.) 3655.213142.92
EV / Net Operating Revenue (X) 4.463.90
EV / EBITDA (X) 26.1621.23
MarketCap / Net Operating Revenue (X) 4.123.52
Retention Ratios (%) 98.5698.87
Price / BV (X) 5.615.33
Price / Net Operating Revenue (X) 4.123.52
EarningsYield 0.020.03
Advertisements
Explore Industry-wise Company financial data